Free SGNA General Patient Care Questions and Answers

Question 1

Unless otherwise specified by the manufacturer, multi-use vials that have been accessed and used should be discarded within which of the following time periods?

Accepted Answer

28 days

Answer

Explanation:
Unless otherwise specified by the manufacturer, multi-use vials that have been accessed and used should be discarded within 28 days. Multi-use vials contain preservatives but can become contaminated with bacteria and provide no protection against viruses. Multi-use vials should be reserved for only one patient whenever possible and should be maintained in a separate space from the treatment area to prevent inadvertent contamination. A new needle and syringe should be used each time the vial is accessed.

Question 2

Which of the following is a reversal agent for excessive sedation of a patient who has received a benzodiazepine?

Accepted Answer

Romazicon (Flumazenil)

Answer

Explanation:
Romazicon (Flumazenil) is a reversal agent for excessive sedation of a patient who has received a benzodiazepine although it does not reverse respiratory depression. Romazicon is administered IV with a beginning dose of 0.2 mg over 30 seconds with repeat doses at one-minute intervals as needed. The second dose is 0.3 mg and the third and subsequent doses are 0.5 mg. Epinephrine is used for emergent treatment of asystole, VF, and PEA; naloxone, for opioids; and N-acetylcysteine, for acetaminophen overdose.

Question 3

A 76-year-old female ate E. coli (0157:H7) contaminated vegetables and developed abdominal cramps and non-bloody diarrhea for 48 hours after which the diarrhea became bloody for 4 days. The patient is MOST at risk for developing which of the following?

Accepted Answer

Hemolytic uremic syndrome

Answer

Explanation:
If a 76-year-old female ate E.coli (0157.H7) contaminated vegetables and developed abdominal cramps and non-bloody diarrhea that persisted for 48 hours after which diarrhea became bloody for 4 days, the patient is at risk for developing hemolytic uremic syndrome (HUS), which can lead to renal failure. Children under 5 and older adults are most likely to develop HUS. HUS is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.

Question 4

A patient taking metoclopramide has been prescribed haloperidol. For which of the following does this drug combination put the patient at increased risk?

Accepted Answer

Tardive dyskinesia

Answer

Explanation:
If a patient taking haloperidol has been prescribed metoclopramide, this drug combination puts the patient at increased risk of developing tardive dyskinesia. Both drugs can cause uncontrollable movement disorders and this combination potentiates the effect and can lead to life-threatening neuroleptic malignant syndrome. The risk of developing tardive dyskinesia with metoclopramide increases with treatment extending beyond 12 weeks. Metoclopramide may also interact with numerous other drugs, including other antipsychotic drugs and phenothiazines.

Question 5

The patient has the right to:

Accepted Answer

All of the above

Answer

Explanation:
Patients have the right to respect and dignity, which means they should be treated with kindness and empathy, and without discrimination. They also have the right to privacy and confidentiality, which means their personal and medical information should be kept confidential and only shared with authorized individuals. Additionally, patients have the right to safety and security, which includes receiving care in a safe environment and being protected from harm. Therefore, all of the options listed (respect and dignity, privacy and confidentiality, safety and security) are rights that patients are entitled to.

SGNA - Society of Gastroenterology Nurses and Associates Practice Test

SGNA - Society of Gastroenterology Nurses and Associates Practice Test

Free SGNA General Patient Care Questions and Answers